Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Hematological Malignancies and Arterial Thromboembolism.

Visweshwar N, Jaglal M, Sokol L, Djulbegovic B.

Indian J Hematol Blood Transfus. 2019 Oct;35(4):611-624. doi: 10.1007/s12288-019-01085-x. Epub 2019 Jan 28. Review.

2.

Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium.

Johnston BC, Zeraatkar D, Han MA, Vernooij RWM, Valli C, El Dib R, Marshall C, Stover PJ, Fairweather-Taitt S, Wójcik G, Bhatia F, de Souza R, Brotons C, Meerpohl JJ, Patel CJ, Djulbegovic B, Alonso-Coello P, Bala MM, Guyatt GH.

Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1621. [Epub ahead of print]

PMID:
31569235
3.

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.

Razavi M, Glasziou P, Klocksieben FA, Ioannidis JPA, Chalmers I, Djulbegovic B.

JAMA Netw Open. 2019 Sep 4;2(9):e1911111. doi: 10.1001/jamanetworkopen.2019.11111.

4.

The importance of randomised vs non-randomised trials.

Djulbegovic B, Glasziou P, Chalmers I.

Lancet. 2019 Aug 24;394(10199):634-635. doi: 10.1016/S0140-6736(19)31128-6. No abstract available.

PMID:
31448731
5.

Evidence vs Consensus in Clinical Practice Guidelines.

Djulbegovic B, Guyatt G.

JAMA. 2019 Jul 19. doi: 10.1001/jama.2019.9751. [Epub ahead of print] No abstract available.

PMID:
31322650
6.

Statins for Primary Prevention of Cardiovascular Disease.

Djulbegovic B, Hozo I.

Ann Intern Med. 2019 Jul 2;171(1):73-74. doi: 10.7326/L19-0261. No abstract available.

PMID:
31261398
7.

Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia.

Talati C, Dhulipala VC, Extermann MT, Ali NA, Kim J, Komrokji R, Sweet K, Kuykendall A, Sehovic M, Reljic T, Djulbegovic B, Lancet JE.

Haematologica. 2020 Jan 31;105(2):398-406. doi: 10.3324/haematol.2018.208637. Print 2020.

8.

A forgotten γ error.

Djulbegovic B, Hozo I.

J Eval Clin Pract. 2019 Oct;25(5):751-753. doi: 10.1111/jep.13155. Epub 2019 May 7. No abstract available.

PMID:
31063238
9.

Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvement.

Djulbegovic B, Bennett CL, Guyatt G.

J Eval Clin Pract. 2019 Jun;25(3):369-372. doi: 10.1111/jep.13146. Epub 2019 Apr 23.

PMID:
31012185
10.

Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

Blood Adv. 2019 Apr 23;3(8):1197-1210. doi: 10.1182/bloodadvances.2018030387. Review.

11.

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update.

Bohlius J, Bohlke K, Castelli R, Djulbegovic B, Lustberg MB, Martino M, Mountzios G, Peswani N, Porter L, Tanaka TN, Trifirò G, Yang H, Lazo-Langner A.

J Clin Oncol. 2019 May 20;37(15):1336-1351. doi: 10.1200/JCO.18.02142. Epub 2019 Apr 10.

12.

Tolerating uncertainty about conceptual models of uncertainty in health care.

Han PKJ, Djulbegovic B.

J Eval Clin Pract. 2019 Apr;25(2):183-185. doi: 10.1111/jep.13110. Epub 2019 Feb 20. No abstract available.

PMID:
30786321
13.

Structured decision-making drives guidelines panels' recommendations "for" but not "against" health interventions.

Djulbegovic B, Reljic T, Elqayam S, Cuker A, Hozo I, Zhou Q, Li SA, Alexander P, Nieuwlaat R, Wiercioch W, Schünemann H, Guyatt G.

J Clin Epidemiol. 2019 Jun;110:23-33. doi: 10.1016/j.jclinepi.2019.02.009. Epub 2019 Feb 16.

PMID:
30779950
14.

The Second Mediterranean Seminar on Science Writing, Editing and Publishing (SWEP - 2018), Sarajevo, December 8th, 2018.

Masic I, Jakovljevic M, Sinanovic O, Gajovic S, Spiroski M, Jusufovic R, Sokolovic S, Prnjavorac B, Zerem E, Djulbegovic B, Porovic S, Jankovic S, Hadzikadic M, Zunic L, Begic E, Nislic E, Begic N, Becirovic E, Cerovac A, Skrijelj V, Nuhanovic J.

Acta Inform Med. 2018 Dec;24(4):284-299. doi: 10.5455/aim.2016.24.284-299. No abstract available.

15.

The threshold model revisited.

Djulbegovic B, Hozo I, Mayrhofer T, van den Ende J, Guyatt G.

J Eval Clin Pract. 2019 Apr;25(2):186-195. doi: 10.1111/jep.13091. Epub 2018 Dec 21.

16.

Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews.

Skoetz N, Goldkuhle M, Weigl A, Dwan K, Labonté V, Dahm P, Meerpohl JJ, Djulbegovic B, van Dalen EC.

J Clin Epidemiol. 2019 Apr;108:1-9. doi: 10.1016/j.jclinepi.2018.12.006. Epub 2018 Dec 10.

PMID:
30543910
17.

A unifying framework for improving health care.

Djulbegovic B, Bennett CL, Guyatt G.

J Eval Clin Pract. 2019 Jun;25(3):358-362. doi: 10.1111/jep.13066. Epub 2018 Nov 21.

PMID:
30461136
18.

Bisphosphonates for Patients Diagnosed With Multiple Myeloma.

Mhaskar R, Djulbegovic B.

JAMA. 2018 Oct 9;320(14):1483-1484. doi: 10.1001/jama.2018.13773.

PMID:
30326511
19.

Evidence to Decision framework provides a structured "roadmap" for making GRADE guidelines recommendations.

Li SA, Alexander PE, Reljic T, Cuker A, Nieuwlaat R, Wiercioch W, Guyatt G, Schünemann HJ, Djulbegovic B.

J Clin Epidemiol. 2018 Dec;104:103-112. doi: 10.1016/j.jclinepi.2018.09.007. Epub 2018 Sep 22.

PMID:
30253221
20.

Precision medicine for individual patients should use population group averages and larger, not smaller, groups.

Djulbegovic B, Ioannidis JPA.

Eur J Clin Invest. 2019 Jan;49(1):e13031. doi: 10.1111/eci.13031. Epub 2018 Oct 15. No abstract available.

PMID:
30251305
21.

Impact of spinal needle type on postdural puncture headache among women undergoing Cesarean section surgery under spinal anesthesia: A meta-analysis.

Lee SI, Sandhu S, Djulbegovic B, Mhaskar RS.

J Evid Based Med. 2018 Aug;11(3):136-144. doi: 10.1111/jebm.12311. Epub 2018 Aug 1.

PMID:
30070060
22.

Heuristic value-based framework for lung cancer decision-making.

Mambetsariev I, Pharaon R, Nam A, Knopf K, Djulbegovic B, Villaflor VM, Vokes EE, Salgia R.

Oncotarget. 2018 Jul 6;9(52):29877-29891. doi: 10.18632/oncotarget.25643. eCollection 2018 Jul 6.

23.

Elective induction of labor at 39 weeks among nulliparous women: The impact on maternal and neonatal risk.

Sinkey RG, Lacevic J, Reljic T, Hozo I, Gibson KS, Odibo AO, Djulbegovic B, Lockwood CJ.

PLoS One. 2018 Apr 25;13(4):e0193169. doi: 10.1371/journal.pone.0193169. eCollection 2018.

24.

Transforming clinical practice guidelines and clinical pathways into fast-and-frugal decision trees to improve clinical care strategies.

Djulbegovic B, Hozo I, Dale W.

J Eval Clin Pract. 2018 Oct;24(5):1247-1254. doi: 10.1111/jep.12895. Epub 2018 Feb 27.

PMID:
29484787
25.

Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval.

Djulbegovic B, Glasziou P, Klocksieben FA, Reljic T, VanDenBergh M, Mhaskar R, Ioannidis JPA, Chalmers I.

J Clin Epidemiol. 2018 Jun;98:24-32. doi: 10.1016/j.jclinepi.2018.01.011. Epub 2018 Feb 10. Review.

PMID:
29432860
26.

Bisphosphonates in multiple myeloma: an updated network meta-analysis.

Mhaskar R, Kumar A, Miladinovic B, Djulbegovic B.

Cochrane Database Syst Rev. 2017 Dec 18;12:CD003188. doi: 10.1002/14651858.CD003188.pub4. Review.

27.

Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials.

Cucchetti A, Piscaglia F, Pinna AD, Djulbegovic B, Mazzotti F, Bolondi L.

Liver Cancer. 2017 Nov;6(4):337-348. doi: 10.1159/000481314. Epub 2017 Oct 19.

28.

Rational decision making in medicine: Implications for overuse and underuse.

Djulbegovic B, Elqayam S, Dale W.

J Eval Clin Pract. 2018 Jun;24(3):655-665. doi: 10.1111/jep.12851. Epub 2017 Dec 1.

29.

On evidence-based medicine - Authors' reply.

Djulbegovic B, Guyatt GH.

Lancet. 2017 Nov 18;390(10109):2245-2246. doi: 10.1016/S0140-6736(17)32854-4. No abstract available.

PMID:
29165267
30.

What does evidence mean? Most languages translate "evidence" into "proof".

Price AI, Djulbegovic B.

J Eval Clin Pract. 2017 Oct;23(5):971-973. doi: 10.1111/jep.12834. No abstract available.

PMID:
28960727
31.

Many faces of rationality: Implications of the great rationality debate for clinical decision-making.

Djulbegovic B, Elqayam S.

J Eval Clin Pract. 2017 Oct;23(5):915-922. doi: 10.1111/jep.12788. Epub 2017 Jul 20.

32.

The predicament of patients with suspected Ebola.

Mayrhofer T, Hamm RM, Van den Ende J, Hozo I, Djulbegovic B.

Lancet Glob Health. 2017 Jul;5(7):e657. doi: 10.1016/S2214-109X(17)30215-2. No abstract available.

33.

Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.

Dahm P, Oxman AD, Djulbegovic B, Guyatt GH, Murad MH, Amato L, Parmelli E, Davoli M, Morgan RL, Mustafa RA, Sultan S, Falck-Ytter Y, Akl EA, Schünemann HJ.

J Clin Epidemiol. 2017 Jun;86:129-139. doi: 10.1016/j.jclinepi.2017.02.019. Epub 2017 Apr 1.

PMID:
28377194
34.

Acceptable regret model in the end-of-life setting: Patients require high level of certainty before forgoing management recommendations.

Tsalatsanis A, Hozo I, Djulbegovic B.

Eur J Cancer. 2017 Apr;75:159-166. doi: 10.1016/j.ejca.2016.12.025. Epub 2017 Feb 22.

PMID:
28235727
35.

Progress in evidence-based medicine: a quarter century on.

Djulbegovic B, Guyatt GH.

Lancet. 2017 Jul 22;390(10092):415-423. doi: 10.1016/S0140-6736(16)31592-6. Epub 2017 Feb 17. Review.

PMID:
28215660
36.

Treatment targeted at underlying disease versus palliative care in terminally ill patients: a systematic review.

Reljic T, Kumar A, Klocksieben FA, Djulbegovic B.

BMJ Open. 2017 Jan 6;7(1):e014661. doi: 10.1136/bmjopen-2016-014661. Review.

37.

Monte Carlo decision curve analysis using aggregate data.

Hozo I, Tsalatsanis A, Djulbegovic B.

Eur J Clin Invest. 2017 Feb;47(2):176-183. doi: 10.1111/eci.12723.

PMID:
28042671
38.

Expected utility versus expected regret theory versions of decision curve analysis do generate different results when treatment effects are taken into account.

Hozo I, Tsalatsanis A, Djulbegovic B.

J Eval Clin Pract. 2018 Feb;24(1):65-71. doi: 10.1111/jep.12676. Epub 2016 Dec 15.

39.

Eliciting regret improves decision making at the end of life.

Djulbegovic B, Tsalatsanis A, Mhaskar R, Hozo I, Miladinovic B, Tuch H.

Eur J Cancer. 2016 Nov;68:27-37. doi: 10.1016/j.ejca.2016.08.027. Epub 2016 Oct 3.

40.

When are clinical trials beneficial for study patients and future patients? A factorial vignette-based survey of institutional review board members.

Mhaskar R, Miladinovic B, Guterbock TM, Djulbegovic B.

BMJ Open. 2016 Sep 28;6(9):e011150. doi: 10.1136/bmjopen-2016-011150.

41.

Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group.

Guyatt GH, Alonso-Coello P, Schünemann HJ, Djulbegovic B, Nothacker M, Lange S, Murad MH, Akl EA.

J Clin Epidemiol. 2016 Dec;80:3-7. doi: 10.1016/j.jclinepi.2016.07.006. Epub 2016 Jul 22. No abstract available.

PMID:
27452192
42.

Iron Supplementation for Chemotherapy-Induced Anemia in Patients Receiving Erythropoiesis-Stimulating Agents.

Mhaskar R, Djulbegovic B.

JAMA Oncol. 2016 Nov 1;2(11):1499-1500. doi: 10.1001/jamaoncol.2016.1864.

PMID:
27387766
43.

Cancer randomized trials showed that dissemination bias is still a problem to be solved.

Urrútia G, Ballesteros M, Djulbegovic B, Gich I, Roqué M, Bonfill X.

J Clin Epidemiol. 2016 Sep;77:84-90. doi: 10.1016/j.jclinepi.2016.04.011. Epub 2016 May 7.

PMID:
27164275
44.

Thrombotic thrombocytopenic purpura: gaining knowledge.

Bennett CL, Djulbegovic B.

Lancet Haematol. 2016 May;3(5):e210-1. doi: 10.1016/S2352-3026(16)30028-X. Epub 2016 Apr 16. No abstract available.

PMID:
27132693
45.

NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.

Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Reu FJ, Singhal S, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R.

J Natl Compr Canc Netw. 2016 Apr;14(4):389-400.

46.

Activating clinical trials: a process improvement approach.

Martinez DA, Tsalatsanis A, Yalcin A, Zayas-Castro JL, Djulbegovic B.

Trials. 2016 Feb 24;17(1):106. doi: 10.1186/s13063-016-1227-2.

47.

GRADE guidelines system is reproducible when instructions are clearly operationalized even among the guidelines panel members with limited experience with GRADE.

Kumar A, Miladinovic B, Guyatt GH, Schünemann HJ, Djulbegovic B.

J Clin Epidemiol. 2016 Jul;75:115-8. doi: 10.1016/j.jclinepi.2015.11.020. Epub 2016 Feb 2.

PMID:
26845745
48.

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents.

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Cochrane Database Syst Rev. 2016 Feb 4;2:CD009624. doi: 10.1002/14651858.CD009624.pub2. Review.

PMID:
26845108
49.

Towards theory integration: Threshold model as a link between signal detection theory, fast-and-frugal trees and evidence accumulation theory.

Hozo I, Djulbegovic B, Luan S, Tsalatsanis A, Gigerenzer G.

J Eval Clin Pract. 2017 Feb;23(1):49-65. doi: 10.1111/jep.12490. Epub 2015 Dec 18.

PMID:
26683386
50.

Rationality, practice variation and person-centred health policy: a threshold hypothesis.

Djulbegovic B, Hamm RM, Mayrhofer T, Hozo I, Van den Ende J.

J Eval Clin Pract. 2015 Dec;21(6):1121-4. doi: 10.1111/jep.12486. Epub 2015 Dec 7.

Supplemental Content

Loading ...
Support Center